Cargando…
Benchmarking Monte-Carlo dose calculation for MLC CyberKnife treatments
BACKGROUND: Vendor-independent Monte Carlo (MC) dose calculation (IDC) for patient-specific quality assurance of multi-leaf collimator (MLC) based CyberKnife treatments is used to benchmark and validate the commercial MC dose calculation engine for MLC based treatments built into the CyberKnife trea...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751815/ https://www.ncbi.nlm.nih.gov/pubmed/31533746 http://dx.doi.org/10.1186/s13014-019-1370-5 |
_version_ | 1783452689899716608 |
---|---|
author | Mackeprang, P.-H. Vuong, D. Volken, W. Henzen, D. Schmidhalter, D. Malthaner, M. Mueller, S. Frei, D. Kilby, W. Aebersold, D. M. Fix, M. K. Manser, P. |
author_facet | Mackeprang, P.-H. Vuong, D. Volken, W. Henzen, D. Schmidhalter, D. Malthaner, M. Mueller, S. Frei, D. Kilby, W. Aebersold, D. M. Fix, M. K. Manser, P. |
author_sort | Mackeprang, P.-H. |
collection | PubMed |
description | BACKGROUND: Vendor-independent Monte Carlo (MC) dose calculation (IDC) for patient-specific quality assurance of multi-leaf collimator (MLC) based CyberKnife treatments is used to benchmark and validate the commercial MC dose calculation engine for MLC based treatments built into the CyberKnife treatment planning system (Precision MC). METHODS: The benchmark included dose profiles in water in 15 mm depth and depth dose curves of rectangular MLC shaped fields ranging from 7.6 mm × 7.7 mm to 115.0 mm × 100.1 mm, which were compared between IDC, Precision MC and measurements in terms of dose difference and distance to agreement. Dose distributions of three phantom cases and seven clinical lung cases were calculated using both IDC and Precision MC. The lung PTVs ranged from 14 cm(3) to 93 cm(3). Quantitative comparison of these dose distributions was performed using dose-volume parameters and 3D gamma analysis with 2% global dose difference and 1 mm distance criteria and a global 10% dose threshold. Time to calculate dose distributions was recorded and efficiency was assessed. RESULTS: Absolute dose profiles in 15 mm depth in water showed agreement between Precision MC and IDC within 3.1% or 1 mm. Depth dose curves agreed within 2.3% / 1 mm. For the phantom and clinical lung cases, mean PTV doses differed from − 1.0 to + 2.3% between IDC and Precision MC and gamma passing rates were > =98.1% for all multiple beam treatment plans. For the lung cases, lung V20 agreed within ±1.5%. Calculation times ranged from 2.2 min (for 39 cm(3) PTV at 1.0 × 1.0 × 2.5 mm(3) native CT resolution) to 8.1 min (93 cm(3) at 1.1 × 1.1 × 1.0 mm(3)), at 2% uncertainty for Precision MC for the 7 examined lung cases and 4–6 h for IDC, which, however, is not optimized for efficiency but used as a gold standard for accuracy. CONCLUSIONS: Both accuracy and efficiency of Precision MC in the context of MLC based planning for the CyberKnife M6 system were benchmarked against MC based IDC framework. Precision MC is used in clinical practice at our institute. |
format | Online Article Text |
id | pubmed-6751815 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-67518152019-09-23 Benchmarking Monte-Carlo dose calculation for MLC CyberKnife treatments Mackeprang, P.-H. Vuong, D. Volken, W. Henzen, D. Schmidhalter, D. Malthaner, M. Mueller, S. Frei, D. Kilby, W. Aebersold, D. M. Fix, M. K. Manser, P. Radiat Oncol Research BACKGROUND: Vendor-independent Monte Carlo (MC) dose calculation (IDC) for patient-specific quality assurance of multi-leaf collimator (MLC) based CyberKnife treatments is used to benchmark and validate the commercial MC dose calculation engine for MLC based treatments built into the CyberKnife treatment planning system (Precision MC). METHODS: The benchmark included dose profiles in water in 15 mm depth and depth dose curves of rectangular MLC shaped fields ranging from 7.6 mm × 7.7 mm to 115.0 mm × 100.1 mm, which were compared between IDC, Precision MC and measurements in terms of dose difference and distance to agreement. Dose distributions of three phantom cases and seven clinical lung cases were calculated using both IDC and Precision MC. The lung PTVs ranged from 14 cm(3) to 93 cm(3). Quantitative comparison of these dose distributions was performed using dose-volume parameters and 3D gamma analysis with 2% global dose difference and 1 mm distance criteria and a global 10% dose threshold. Time to calculate dose distributions was recorded and efficiency was assessed. RESULTS: Absolute dose profiles in 15 mm depth in water showed agreement between Precision MC and IDC within 3.1% or 1 mm. Depth dose curves agreed within 2.3% / 1 mm. For the phantom and clinical lung cases, mean PTV doses differed from − 1.0 to + 2.3% between IDC and Precision MC and gamma passing rates were > =98.1% for all multiple beam treatment plans. For the lung cases, lung V20 agreed within ±1.5%. Calculation times ranged from 2.2 min (for 39 cm(3) PTV at 1.0 × 1.0 × 2.5 mm(3) native CT resolution) to 8.1 min (93 cm(3) at 1.1 × 1.1 × 1.0 mm(3)), at 2% uncertainty for Precision MC for the 7 examined lung cases and 4–6 h for IDC, which, however, is not optimized for efficiency but used as a gold standard for accuracy. CONCLUSIONS: Both accuracy and efficiency of Precision MC in the context of MLC based planning for the CyberKnife M6 system were benchmarked against MC based IDC framework. Precision MC is used in clinical practice at our institute. BioMed Central 2019-09-18 /pmc/articles/PMC6751815/ /pubmed/31533746 http://dx.doi.org/10.1186/s13014-019-1370-5 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Mackeprang, P.-H. Vuong, D. Volken, W. Henzen, D. Schmidhalter, D. Malthaner, M. Mueller, S. Frei, D. Kilby, W. Aebersold, D. M. Fix, M. K. Manser, P. Benchmarking Monte-Carlo dose calculation for MLC CyberKnife treatments |
title | Benchmarking Monte-Carlo dose calculation for MLC CyberKnife treatments |
title_full | Benchmarking Monte-Carlo dose calculation for MLC CyberKnife treatments |
title_fullStr | Benchmarking Monte-Carlo dose calculation for MLC CyberKnife treatments |
title_full_unstemmed | Benchmarking Monte-Carlo dose calculation for MLC CyberKnife treatments |
title_short | Benchmarking Monte-Carlo dose calculation for MLC CyberKnife treatments |
title_sort | benchmarking monte-carlo dose calculation for mlc cyberknife treatments |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751815/ https://www.ncbi.nlm.nih.gov/pubmed/31533746 http://dx.doi.org/10.1186/s13014-019-1370-5 |
work_keys_str_mv | AT mackeprangph benchmarkingmontecarlodosecalculationformlccyberknifetreatments AT vuongd benchmarkingmontecarlodosecalculationformlccyberknifetreatments AT volkenw benchmarkingmontecarlodosecalculationformlccyberknifetreatments AT henzend benchmarkingmontecarlodosecalculationformlccyberknifetreatments AT schmidhalterd benchmarkingmontecarlodosecalculationformlccyberknifetreatments AT malthanerm benchmarkingmontecarlodosecalculationformlccyberknifetreatments AT muellers benchmarkingmontecarlodosecalculationformlccyberknifetreatments AT freid benchmarkingmontecarlodosecalculationformlccyberknifetreatments AT kilbyw benchmarkingmontecarlodosecalculationformlccyberknifetreatments AT aebersolddm benchmarkingmontecarlodosecalculationformlccyberknifetreatments AT fixmk benchmarkingmontecarlodosecalculationformlccyberknifetreatments AT manserp benchmarkingmontecarlodosecalculationformlccyberknifetreatments |